Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 10/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.48 |
| ▸ | NR4A3 | Q92570 | 2/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.44 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25788251 | 0.87 | NR4A2 (0.52) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 | |
| SCHEMBL25788247 | 0.87 | KMT2A (0.55) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 | |
| SCHEMBL25788254 | 0.85 | USP2 (0.53) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 | |
| SCHEMBL2946154 | 0.83 | NR4A2 (0.63) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 | |
| SCHEMBL30281213 | 0.83 | NR4A2 (0.63) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 | |
| SCHEMBL25790173 | 0.82 | TSHR (0.55) | NR4A2NR4A1NR4A3NPC1RAB9A | |
| SCHEMBL9147206 | 0.81 | TSHR (0.57) | NR4A2NR4A1NR4A3NPC1RAB9A | |
| SCHEMBL9141748 | 0.81 | TSHR (0.57) | NR4A2NR4A1NR4A3NPC1RAB9A | |
| SCHEMBL9143125 | 0.77 | TSHR (0.52) | NR4A2NR4A1NR4A3NPC1RAB9A | |
| SCHEMBL848890 | 0.77 | KMT2A (0.60) | NR4A2KMT2AMRGPRX4NR4A1NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A9, SLC6A5, REN | NR4A2 2712/4885KMT2A 2175/4885MRGPRX4 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.